Neogen Chemicals Limited has announced a strategic infusion of equity capital by a member of its promoter group. Cadamba Solutions Private Limited has acquired 10,00,000 equity shares of the company on a preferential basis. This transaction, completed on April 18, 2026, represents a total investment of Rs. 1,61,00,00,000. The move highlights the continued confidence of the promoter group in the long-term growth and operational prospects of the company.
Details of the Preferential Allotment
In a significant financial development, Neogen Chemicals Limited has successfully issued 10,00,000 equity shares to Cadamba Solutions Private Limited, a constituent of the company’s promoter group. The shares were issued at a price of Rs. 1,610 per share, which includes a premium of Rs. 1,600 over the face value of Rs. 10 per share. The total consideration for this preferential allotment amounts to Rs. 1,61,00,00,000.
Impact on Shareholding Structure
This transaction has altered the company’s capital structure. Following the allotment, the new shares represent 3.79% of the pre-allotment paid-up equity capital and 3.65% of the post-allotment paid-up equity capital. The company’s total paid-up capital has increased to Rs. 27,38,16,740, comprising 2,73,81,674 equity shares. This capital infusion provides the company with additional resources to support its ongoing business objectives and strategic initiatives.
Source: BSE
